https://www.selleckchem.com/products/gdc-1971.html
4±2.6%, 75.9±6.3%, and 53.7±12.7%, respectively (p=0.00. After adjusting for confounding variables, ENE+ was associated with more than five times the hazard of death than pN- cases (p=0.00, and more than twice the hazard of death than ENE- cases (p=0.036). Compared to N2-3/ENE- cases, N2-3/ENE+ cases had the poorest survival rate (p=0.013). ENE+ was associated with worse outcomes compared to pN - or ENE- status. ENE is an independent prognostic factor in LSCC, and could be an indicator of the need for adjuvant treatment.Aims To eva